An α-hydroxy acid
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

D-α-Hydroxyglutaric Acid (sodium salt)

Item No. 11605

Technical Information
Formal Name
2R-hydroxy-pentanedioic acid, disodium salt
CAS Number
103404-90-6
Synonyms
  • D-2-HG
  • D-2-Hydroxyglutaric Acid
  • DGA
  • R-2HG
Molecular Formula
C5H6O5 • 2Na
Formula Weight
Purity
≥95%
A crystalline solid
PBS (pH 7.2): 10 mg/ml
SMILES
[O-]C(CC[C@@H](O)C([O-])=O)=O.[Na+].[Na+]
InChi Code
InChI=1S/C5H8O5.2Na/c6-3(5(9)10)1-2-4(7)8;;/h3,6H,1-2H2,(H,7,8)(H,9,10);;/q;2*+1/p-2/t3-;;/m1../s1
InChi Key
DZHFTEDSQFPDPP-HWYNEVGZSA-L
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    D-α-Hydroxyglutaric acid (D-2-HG) is an α-hydroxy acid.1 It decreases the oxygen consumption rate (OCR) and ratio of ATP to ADP in U87 glioma cells when used at a concentration of 800 µM. D-2-HG (100 µM) increases the levels of thiobarbituric acid reactive substances (TBARS) in isolated rat cerebral cortex homogenates.2 Urinary levels of D-2-HG are increased in D-2-hydroxyglutaric aciduria, a neurometabolic disease characterized by epilepsy, muscle hypotonia, and delays in psychomotor development.3,4 D-2-HG is structurally similar to α-ketoglutarate, the product of wild-type isocitrate dehydrogenases, and competitively inhibits α-ketoglutarate-dependent dioxygenases, including histone lysine demethylases and DNA hydroxylases.5,6,7

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Fu, X., Chin, R.M., Vergnes, L., et al2-Hydroxyglutarate inhibits ATP synthase and mTOR signaling. Cell Metab. 22(3), 508-515 (2015).

    2. Latini, A., Scussiato, K., Rosa, R.B., et alD-2-hydroxyglutaric acid induces oxidative stress in cerebral cortex of young rats. Eur. J. Neurosci. 17(10), 2017-2022 (2003).

    3. Kranendijk, M., Struys, E.A., Van Schaftingen, E., et alIDH2 Mutations in Patients with D-2-Hydroxyglutaric Aciduria. Science 330(6002), 336 (2014).

    4. Struys, E.A., Salomons, G.S., Achouri, Y., et alMutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. Am. J. Hum. Genet. 76(2), 358-360 (2005).

    5. Yang, H., Ye, D., Guan, K.L., et alIDH1 and IDH2 mutations in tumorigenesis: Mechanistic insights and clinical perspectives. Clin. Cancer Res. 18(20), 5562-5571 (2012).

    6. Xu, W., Yang, H., Liu, Y., et alOncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19(1), 17-30 (2011).

    7. Chowdhury, R., Yeoh, K.K., Tian, Y.M., et alThe oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 12(5), 463-469 (2011).